Home Details
| Official Symbol of Gene | CAMP |
| Species | Homo sapiens |
| Entrez Gene ID | 820 |
| Official Full Name | cathelicidin antimicrobial peptide |
| Also known as | LL37; CAP18; CRAMP; HSD26; CAP-18; FALL39; FALL-39 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000164047 MIM:600474; AllianceGenome:HGNC:1472 |
| Map Location | 3p21.31 |
| Drug | F2-9 |
| Interaction Type | activator |
| Descent | NA |
| Disease | MS |
| Pubmed ID | 27913115 |
| Year | 2016 |
| Title | Computer design, synthesis, and bioactivity analyses of drugs like Fingolimod used in the treatment of Multiple Sclerosis |
| Result | In summary, our data demonstrate that the two novel FTY720 derivatives act as anti-inflammatory ultimately by influencing the gene expression via the cAMP and downstream transcription factor CRE pathway |
| Mechanism/pathway | Fingolimod (FTY720) is an orally active immunomodulatory drug that has been used for the treatment of relapsing-remitting multiple sclerosis. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.